Association Between PD-1 and PD-L1 Inhibitor Use and the Development of Keratoacanthoma and Cutaneous Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Keratoacanthoma and Cutaneous Squamous Cell Carcinoma With PD-1 and PD-L1 Inhibitor Use
JAMA Dermatol 2024 Apr 10;[EPub Ahead of Print], P Aggarwal, D Clark, A Shah, K Rismiller, SA NeltnerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.